A modular cell-culture platform demonstrates accelerated process development.
Thomas Wucherpfennig
Advertisement
Thomas Wucherpfennig is scientist, cell culture development at Boehringer Ingelheim Pharma GmbH & Co. KG.
Articles by Thomas Wucherpfennig
Advertisement
Latest Updated Articles
Platform Approach Speeds Process DevelopmentApril 1st 2016
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5